Related Experiment Videos

Predictors of favourable outcome in inflammatory Crohn's disease. A retrospective observational study

Yamile Zabana1, Esther Garcia-Planella, Manuel van Domselaar

  • 1Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Spain.

Gastroenterologia Y Hepatologia
|September 12, 2013
PubMed

Insights

Predicting a favorable outcome in Crohn's disease (CD) is challenging. However, isolated colonic involvement at diagnosis may indicate a less aggressive disease course, potentially allowing for conservative management.

Area of Science:

  • Gastroenterology
  • Internal Medicine
  • Clinical Research

Background:

  • Predicting favorable outcomes in adult Crohn's disease (CD) to guide conservative management is lacking.
  • This study aimed to identify early predictors of a favorable disease course in CD patients.

Purpose of the Study:

  • To identify predictors of a favorable disease course in adult Crohn's disease (CD) at the time of diagnosis.
  • To inform conservative therapeutic approaches for CD.

Main Methods:

  • Retrospective analysis of 145 adult CD patients diagnosed between 1994-2003 with inflammatory patterns and no perianal disease.
  • Follow-up for at least 5 years, defining a favorable outcome as absence of complications (stricturing, penetrating, perianal disease) and no need for anti-TNF therapy or surgery.
  • Collected clinical, therapeutic features, and follow-up data until 2008.

Main Results:

  • 57% of patients (82/145) achieved a favorable outcome after a median follow-up of 96 months.
  • Isolated colonic involvement at diagnosis was the sole predictor of a favorable outcome (P=0.022).
  • Patients with isolated colonic disease had a 73% favorable outcome rate.

Conclusions:

  • Predicting a favorable outcome in initially uncomplicated Crohn's disease (CD) using clinical or epidemiological factors is difficult.
  • Isolated colonic disease is associated with a less aggressive disease course in CD patients.
  • This finding may support conservative management strategies in select CD patients.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...